Xi Bing Ang

Xi Bing Ang is a Partner based in the London office of Simon-Kucher & Partners. He specialises in pricing and growth strategies for B2B software companies as well as B2B data & intelligence providers.

Ellen Kan

Ellen is a partner in Simon-Kucher’s New York office and has been with the company since 2012. She specializes in smarter go-to-market, monetization, and pricing strategies to help companies drive top-line growth. Her consulting experience spans a breadth of consumer and retail companies, with a particular focus on fast-moving consumer goods, eCommerce, and digitally native consumer brands.

Verena De Smedt-Zuegner

Verena is a Partner in Simon-Kucher’s Software and Internet practice. She is based in the Vienna office while working with clients internationally.​

Martin Gehring

Martin Gehring is a Senior Partner at Simon-Kucher and head of the company's Global Automotive Practice in Cologne. He has managed projects for some of the most successful automotive manufacturers, suppliers, wholesalers and retailers, focusing on improving their pricing, product and sales strategies.

Gunnar Clausen

グンナー・クラウゼン博士はサイモン・クチャーのシニアパートナー兼共同最高経営責任者（CEO）である。 2025年1月1日より、中欧および北欧担当マネージングパートナーを経て、共同CEOに就任。 サイモン・クチャーでの20年間のキャリアにおいて、成長戦略・競争戦略、市場参入戦略、製品戦略・価格戦略、CRM、デジタル・トランスフォーションに関する幅広い専門知識を培ってきた。

データプライバシー

Ruben de Lange

Ruben de Lange is a Partner at Simon-Kucher's Amsterdam office. He leverages his experience in software to design winning monetization models for software companies.

Alexander Bilsing

Alexander is a partner at Simon-Kucher and works out of the Cologne office. He is a member of the global Consumer sector.

Carles Munich

Carles is a Senior Director within the Consumer practice at Simon-Kucher, focusing his work on the restaurant, leisure and travel industries.

Chuck Gammal

Chuck is a Partner and Practice Head Healthcare at Simon-Kucher. He supports healthcare companies across sub-sectors, including medical technology, healthcare services, and healthcare IT. He also advises pharmaceutical and biotechnology companies on new business models for digital technologies.